Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
146.63
+4.32 (3.04%)
Jul 2, 2026, 4:00 PM EDT - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $5.77 billion as of July 2, 2026. Its market cap has increased by 202.73% in one year.
Market Cap
5.77B
Enterprise Value
5.28B
1-Year Change
202.73%
Ranking
Category
Stock Price
$146.63
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $5.77B, an increase of 3,890.00%. That is a compound annual growth rate of 141.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 5.77B | -3.87% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 6.33B |
| CG Oncology | 6.21B |
| Xenon Pharmaceuticals | 5.89B |
| Definium Therapeutics | 5.87B |
| CRISPR Therapeutics AG | 5.79B |
| Legend Biotech | 5.79B |
| Erasca | 5.74B |
| Veradermics | 5.42B |